Also known as Sandostatin and Sandostatin Lar
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.Source: Wikipedia
Estimated Total Cost: $1745.49 for an average of 21 days supply
Patients are most commonly prescribed octreotide to treat metastatic cancer, gastrointestinal hemorrhage, blood in stool, and vomiting blood.